Allspring Global Investments Holdings LLC Lowers Stake in Encompass Health Co. (NYSE:EHC)

Allspring Global Investments Holdings LLC lessened its holdings in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 31.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,713 shares of the company's stock after selling 21,415 shares during the period. Allspring Global Investments Holdings LLC's holdings in Encompass Health were worth $4,199,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. TD Private Client Wealth LLC grew its stake in Encompass Health by 2,870.0% during the 3rd quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company's stock valued at $709,000 after acquiring an additional 7,089 shares in the last quarter. Los Angeles Capital Management LLC grew its stake in Encompass Health by 532.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company's stock valued at $4,860,000 after acquiring an additional 42,338 shares in the last quarter. Pathstone Holdings LLC grew its stake in Encompass Health by 54.5% during the 3rd quarter. Pathstone Holdings LLC now owns 21,022 shares of the company's stock valued at $2,032,000 after acquiring an additional 7,412 shares in the last quarter. Meeder Asset Management Inc. grew its stake in Encompass Health by 43.8% during the 3rd quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company's stock valued at $6,417,000 after acquiring an additional 20,242 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in Encompass Health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company's stock valued at $161,781,000 after purchasing an additional 20,547 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Remove Ads

Insiders Place Their Bets

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 2.10% of the stock is owned by company insiders.

Encompass Health Stock Up 1.4 %

Encompass Health stock traded up $1.33 during mid-day trading on Monday, reaching $98.86. 465,200 shares of the company's stock were exchanged, compared to its average volume of 655,234. The company has a market cap of $9.96 billion, a P/E ratio of 22.17, a P/E/G ratio of 2.31 and a beta of 0.90. Encompass Health Co. has a twelve month low of $73.68 and a twelve month high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The company has a fifty day moving average of $96.01 and a 200-day moving average of $96.05.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Sell-side analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 17th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.69%. Encompass Health's dividend payout ratio (DPR) is presently 15.25%.

Analyst Ratings Changes

Several equities analysts have weighed in on EHC shares. KeyCorp boosted their target price on shares of Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a report on Monday, February 10th. Royal Bank of Canada reiterated an "outperform" rating and issued a $110.00 target price on shares of Encompass Health in a report on Tuesday, February 11th. William Blair reiterated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Truist Financial reiterated a "buy" rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Finally, Barclays boosted their target price on shares of Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a report on Friday, February 7th. Ten investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $107.67.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.